Literature DB >> 24907707

Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansion.

Yan Li1, Mahboobeh Safaeian2, Hilary A Robbins2, Barry I Graubard3.   

Abstract

Epidemiologic cross-sectional, case-cohort, or case-control studies often select augmentation samples to supplement an existing (baseline) sample, primarily for the two reasons: (1) to increase the sample sizes from certain subdomains of interest that were not originally considered in the design of the baseline study and (2) to obtain samples from an extension of the target population. To address these two objectives, two-stage stratified sample designs are considered, where the stratification based on the expanded population at the second stage is not nested in the first stage strata. The sample weighting and Taylor linearization variance estimation for the two-stage stratified sample designs, involving re-stratification and population expansion, are provided for estimating population totals and logistic regression coefficients. Results from limited simulation studies and a logistic regression analysis of a study of human papillomavirus serology are provided.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Pseudo-likelihood function; Sample weighting; Taylor linearization variance estimation; Two-stage stratified sampling

Mesh:

Year:  2014        PMID: 24907707      PMCID: PMC4263221          DOI: 10.1093/biostatistics/kxu024

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  9 in total

1.  Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.

Authors:  Sarah E Coseo; Carolina Porras; Lori E Dodd; Allan Hildesheim; Ana Cecilia Rodriguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Silvia Jimenez; Diane Solomon; Catherine Bougelet; Leen-Jan van Doorn; Wim Quint; Mahboobeh Safaeian
Journal:  Sex Transm Dis       Date:  2011-10       Impact factor: 2.830

2.  Piecewise exponential survival times and analysis of case-cohort data.

Authors:  Yan Li; Mitchell H Gail; Dale L Preston; Barry I Graubard; Jay H Lubin
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

3.  Using the Peters--Belson method to measure health care disparities from complex survey data.

Authors:  B I Graubard; R Sowmya Rao; Joseph L Gastwirth
Journal:  Stat Med       Date:  2005-09-15       Impact factor: 2.373

4.  Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Peter J F Snijders; Rolando Herrero; Chris J L M Meijer; Martyn Plummer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

5.  A two stage design for the study of the relationship between a rare exposure and a rare disease.

Authors:  J E White
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

6.  Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.

Authors:  Sarah Coseo; Carolina Porras; Allan Hildesheim; Ana Cecilia Rodriguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Paula Gonzalez; Sophia S Wang; Mark E Sherman; Silvia Jimenez; Diane Solomon; Catherine Bougelet; Leen-Jan van Doorn; Wim Quint; Mahboobeh Safaeian
Journal:  Sex Transm Dis       Date:  2010-11       Impact factor: 2.830

7.  Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Allan Hildesheim; Ana C Rodríguez; Sholom Wacholder; Concepción Bratti; Diane Solomon; Paula González; Carolina Porras; Silvia Jiménez; Diego Guillen; Jorge Morales; Mario Alfaro; Jean Cyr; Kerrygrace Morrisey; Yenory Estrada; Bernal Cortés; Lidia Ana Morera; Enrique Freer; John Schussler; John Schiller; Douglas Lowy; Mark Schiffman
Journal:  Vaccine       Date:  2008-07-18       Impact factor: 3.641

8.  Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.

Authors:  Mark Schiffman; Gary Clifford; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2009-06-01       Impact factor: 2.965

9.  Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.

Authors:  Hilary A Robbins; Yan Li; Carolina Porras; Michael Pawlita; Arpita Ghosh; Ana Cecilia Rodriguez; Mark Schiffman; Sholom Wacholder; Troy J Kemp; Paula Gonzalez; John Schiller; Douglas Lowy; Mark Esser; Katie Matys; Wim Quint; Leen-Jan van Doorn; Rolando Herrero; Ligia A Pinto; Allan Hildesheim; Tim Waterboer; Mahboobeh Safaeian
Journal:  BMC Infect Dis       Date:  2014-03-03       Impact factor: 3.090

  9 in total
  2 in total

1.  Socioeconomic differences in self-medication among middle-aged and older people: data from the China health and retirement longitudinal study.

Authors:  Jie Chang; Qing Wang; Yu Fang
Journal:  BMJ Open       Date:  2017-12-19       Impact factor: 2.692

2.  A comprehensive tool for measuring mammographic density changes over time.

Authors:  Mikael Eriksson; Jingmei Li; Karin Leifland; Kamila Czene; Per Hall
Journal:  Breast Cancer Res Treat       Date:  2018-02-01       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.